Shu Xu
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine 2
-
- Adipose Tissue and Metabolism 3
-
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 2
-
- Mitochondrial Function and Pathology 2
-
- Apelin-related biomedical research 2
-
- Cardiac Ischemia and Reperfusion 2
-
- Hormonal Regulation and Hypertension 2
-
- Gastroesophageal reflux and treatments 1
In The Last Decade
Shu Xu
15 papers receiving 317 citations
Peers
Comparison fields: 5 of 72
- Geriatrics and Gerontology 38
- Cancer Research 57
- Cardiology and Cardiovascular Medicine 79
- Physiology 15
- Endocrine and Autonomic Systems 21
Countries citing papers authored by Shu Xu
This map shows the geographic impact of Shu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Xu more than expected).
Fields of papers citing papers by Shu Xu
This network shows the impact of papers produced by Shu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Xu. The network helps show where Shu Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 175 | |
| 10 | 2019 | 1 | |
| 11 | 2018 | 52 | |
| 12 | 2018 | 28 | |
| 13 | 2017 | 12 | |
| 14 | 2016 | 23 | |
| 15 | 2016 | 1 | |
| 16 | 2015 | 9 |
About Shu Xu
Shu Xu is a scholar working on Geriatrics and Gerontology, Gastroenterology and Physiology, having authored 16 papers that have together received 319 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (3 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers), Mitochondrial Function and Pathology (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Apelin-related biomedical research (2 papers), Cardiac Ischemia and Reperfusion (2 papers), Hormonal Regulation and Hypertension (2 papers) and Gastroesophageal reflux and treatments (1 paper). The work is most often cited by research in Geriatrics and Gerontology (38 citations), Cancer Research (57 citations) and Cardiology and Cardiovascular Medicine (79 citations). Shu Xu has collaborated with scholars based in China and Canada. Frequent co-authors include Huishan Wang, Xiaodong Xue, Liming Yu, Yinli Xu, Yang Yang, Xue Dong, Zhishang Wang, Yang Wang, Hao Gao and Zhi Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.